Recombinant Vaccine Market Report

Europe Recombinant Vaccine Market Size, Status and Forecast 2014-2026

  • POSTDATE：Jun 19, 2020
  • PAGES：177
  • REPORT CODE：GMM558763
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Recombinant Vaccine market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 2.4% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Recombinant Vaccine Market Segmentations:

    By Player:

    • GlaxoSmithKline Plc

    • Bharat Biotech

    • Protein Science Corporation

    • Green Cross Corporation

    • Novartis AG

    By Type:

    • Subunit Recombinant Vaccines

    • Attenuated Recombinant Vaccines

    • Vector Recombinant Vaccines

    By End-User:

    • Human

    • Animal

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Recombinant Vaccine Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Recombinant Vaccine Market Size and Growth Rate of Subunit Recombinant Vaccines from 2014 to 2026

    • 1.3.2 Europe Recombinant Vaccine Market Size and Growth Rate of Attenuated Recombinant Vaccines from 2014 to 2026

    • 1.3.3 Europe Recombinant Vaccine Market Size and Growth Rate of Vector Recombinant Vaccines from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Recombinant Vaccine Market Size and Growth Rate of Human from 2014 to 2026

    • 1.4.2 Europe Recombinant Vaccine Market Size and Growth Rate of Animal from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Recombinant Vaccine Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Recombinant Vaccine by Major Types

      • 3.4.1 Market Size and Growth Rate of Subunit Recombinant Vaccines

      • 3.4.2 Market Size and Growth Rate of Attenuated Recombinant Vaccines

      • 3.4.3 Market Size and Growth Rate of Vector Recombinant Vaccines

    4 Segmentation of Recombinant Vaccine Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Recombinant Vaccine by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Human for Construction

      • 4.4.2 Market Size and Growth Rate of Animal for Construction

    5 Market Analysis by Major Regions

    • 5.1 Europe Recombinant Vaccine Production Analysis by Top Regions

    • 5.2 Europe Recombinant Vaccine Consumption Analysis by Top Regions

    • 5.3 Europe Recombinant Vaccine Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.3 France Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Production, Import, Consumption and Export Analysis

    6 Product Circulation of Recombinant Vaccine Market among Top Countries

    • 6.1 Top 5 Export Countries in Recombinant Vaccine Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Recombinant Vaccine Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Recombinant Vaccine Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Recombinant Vaccine Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Recombinant Vaccine Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Recombinant Vaccine Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Recombinant Vaccine Landscape Analysis

    • 7.1 Germany Recombinant Vaccine Landscape Analysis by Major Types

    • 7.2 Germany Recombinant Vaccine Landscape Analysis by Major End-Users

    8. UK Recombinant Vaccine Landscape Analysis

    • 8.1 UK Recombinant Vaccine Landscape Analysis by Major Types

    • 8.2 UK Recombinant Vaccine Landscape Analysis by Major End-Users

    9. France Recombinant Vaccine Landscape Analysis

    • 9.1 France Recombinant Vaccine Landscape Analysis by Major Types

    • 9.2 France Recombinant Vaccine Landscape Analysis by Major End-Users

    10. Italy Recombinant Vaccine Landscape Analysis

    • 10.1 Italy Recombinant Vaccine Landscape Analysis by Major Types

    • 10.2 Italy Recombinant Vaccine Landscape Analysis by Major End-Users

    11. Spain Recombinant Vaccine Landscape Analysis

    • 11.1 Spain Recombinant Vaccine Landscape Analysis by Major Types

    • 11.2 Spain Recombinant Vaccine Landscape Analysis by Major End-Users

    12. Poland Recombinant Vaccine Landscape Analysis

    • 12.1 Poland Recombinant Vaccine Landscape Analysis by Major Types

    • 12.2 Poland Recombinant Vaccine Landscape Analysis by Major End-Users

    13. Russia Recombinant Vaccine Landscape Analysis

    • 13.1 Russia Recombinant Vaccine Landscape Analysis by Major Types

    • 13.2 Russia Recombinant Vaccine Landscape Analysis by Major End-Users

    14. Switzerland Recombinant Vaccine Landscape Analysis

    • 14.1 Switzerland Recombinant Vaccine Landscape Analysis by Major Types

    • 14.2 Switzerland Recombinant Vaccine Landscape Analysis by Major End-Users

    15. Turkey Recombinant Vaccine Landscape Analysis

    • 15.1 Turkey Recombinant Vaccine Landscape Analysis by Major Types

    • 15.2 Turkey Recombinant Vaccine Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Landscape Analysis by Top Countries

      • 16.3.1 Denmark Recombinant Vaccine Market Volume and Growth Rate

      • 16.3.2 Finland Recombinant Vaccine Market Volume and Growth Rate

      • 16.3.3 Norway Recombinant Vaccine Market Volume and Growth Rate

      • 16.3.4 Sweden Recombinant Vaccine Market Volume and Growth Rate

      • 16.3.6 Iceland Recombinant Vaccine Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Landscape Analysis by Top Countries

      • 17.3.1 Belgium Recombinant Vaccine Market Volume and Growth Rate

      • 17.3.2 Netherlands Recombinant Vaccine Market Volume and Growth Rate

      • 17.3.3 Luxembourg Recombinant Vaccine Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Landscape Analysis by Top Countries

      • 18.3.1 Estonia Recombinant Vaccine Market Volume and Growth Rate

      • 18.3.2 Latvia Recombinant Vaccine Market Volume and Growth Rate

      • 18.3.3 Lithuania Recombinant Vaccine Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 GlaxoSmithKline Plc

      • 19.1.1 GlaxoSmithKline Plc Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 Bharat Biotech

      • 19.2.1 Bharat Biotech Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 Protein Science Corporation

      • 19.3.1 Protein Science Corporation Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Green Cross Corporation

      • 19.4.1 Green Cross Corporation Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 Novartis AG

      • 19.5.1 Novartis AG Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    The List of Tables and Figures (Totals 116 Figures and 167 Tables)

    • Figure Product Picture

    • Figure Recombinant Vaccine Market Size and Growth Rate of Subunit Recombinant Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Recombinant Vaccine Market Size and Growth Rate of Attenuated Recombinant Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Recombinant Vaccine Market Size and Growth Rate of Vector Recombinant Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Recombinant Vaccine Market Size and Growth Rate of Human from 2014 to 2026

    • Figure Recombinant Vaccine Market Size and Growth Rate of Animal from 2014 to 2026

    • Figure Germany Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure UK Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure France Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Recombinant Vaccine Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Recombinant Vaccine Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Recombinant Vaccine

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Recombinant Vaccine by Different Types from 2014 to 2026

    • Table Consumption Share of Recombinant Vaccine by Different Types from 2014 to 2026

    • Figure Recombinant Vaccine Market Size and Growth Rate of Subunit Recombinant Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Recombinant Vaccine Market Size and Growth Rate of Attenuated Recombinant Vaccines Market, 2015 - 2026 (USD Million)

    • Figure Recombinant Vaccine Market Size and Growth Rate of Vector Recombinant Vaccines Market, 2015 - 2026 (USD Million)

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Recombinant Vaccine by Different End-Users from 2014 to 2026

    • Table Consumption Share of Recombinant Vaccine by Different End-Users from 2014 to 2026

    • Figure Recombinant Vaccine Market Size and Growth Rate of Human from 2014 to 2026

    • Figure Recombinant Vaccine Market Size and Growth Rate of Animal from 2014 to 2026

    • Table Europe Recombinant Vaccine Production by Major Regions

    • Table Europe Recombinant Vaccine Production Share by Major Regions

    • Figure Europe Recombinant Vaccine Production Share by Major Countries and Regions in 2014

    • Table Europe Recombinant Vaccine Consumption by Major Regions

    • Table Europe Recombinant Vaccine Consumption Share by Major Regions

    • Table Germany Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table UK Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table France Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Italy Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Spain Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Poland Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Russia Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Switzerland Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Turkey Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Recombinant Vaccine Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Recombinant Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Recombinant Vaccine Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Recombinant Vaccine Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table Germany Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table Germany Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table Germany Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table UK Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table UK Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table UK Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table UK Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table France Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table France Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table France Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table France Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Italy Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table Italy Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table Italy Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table Italy Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Spain Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table Spain Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table Spain Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table Spain Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Poland Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table Poland Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table Poland Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table Poland Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Russia Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table Russia Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table Russia Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table Russia Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table Switzerland Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table Switzerland Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table Switzerland Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table Turkey Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table Turkey Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table Turkey Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Recombinant Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Recombinant Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Recombinant Vaccine Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Recombinant Vaccine Market Volume and Growth Rate from 2014 to 2026

    • Table GlaxoSmithKline Plc Profiles

    • Table GlaxoSmithKline Plc Production, Value, Price, Gross Margin 2014-2019

    • Table GlaxoSmithKline Plc Product benchmarking

    • Table GlaxoSmithKline Plc Strategic initiatives

    • Table GlaxoSmithKline Plc SWOT analysis

    • Table Bharat Biotech Profiles

    • Table Bharat Biotech Production, Value, Price, Gross Margin 2014-2019

    • Table Bharat Biotech Product benchmarking

    • Table Bharat Biotech Strategic initiatives

    • Table Bharat Biotech SWOT analysis

    • Table Protein Science Corporation Profiles

    • Table Protein Science Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Protein Science Corporation Product benchmarking

    • Table Protein Science Corporation Strategic initiatives

    • Table Protein Science Corporation SWOT analysis

    • Table Green Cross Corporation Profiles

    • Table Green Cross Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Green Cross Corporation Product benchmarking

    • Table Green Cross Corporation Strategic initiatives

    • Table Green Cross Corporation SWOT analysis

    • Table Novartis AG Profiles

    • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

    • Table Novartis AG Product benchmarking

    • Table Novartis AG Strategic initiatives

    • Table Novartis AG SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US